Mulard; Laurence

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mulard; Laurence.The latest application filed is for "heat-stable enterotoxins mutants as antidiarrheal vaccine antigens".

Company Profile

3.9.16

Mulard; Laurence - Paris Cede 15 FR
MULARD; Laurence - Le Kremlin Bicetre FR
Mulard; Laurence - Le Kremlin-Bic tre FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens App 20220249644 - Puntervoll; Pal ; et al.	2022-08-11
Polyclonal Antibodies Specific For Serogroup X Of N. Meningitidis And Uses Thereof In Diagnosis App 20210095009 - TAHA; Muhamed-Kheir ; et al.	2021-04-01
Polyclonal antibodies specific for serogroup x of N. meningitidis and uses thereof in diagnosis Grant 10,822,398 - Taha , et al. November 3, 2	2020-11-03
Protected Tetrasaccharides, Their Process Of Preparation And Their Use As Transglucosylase Acceptor Substrates In The Chemo-enzy App 20200165285 - MULARD; Laurence ; et al.	2020-05-28
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri Grant 10,376,593 - Mulard , et al. A	2019-08-13
Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X Grant 10,087,242 - Mulard , et al. October 2, 2	2018-10-02
Polyclonal Antibodies Specific For Serogroup X Of N. Meningitidis And Uses Thereof In Diagnosis App 20170334975 - TAHA; Muhamed-Kheir ; et al.	2017-11-23
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri Grant 9,446,109 - Phalipon , et al. September 20, 2	2016-09-20
Glycoconjugates And Their Use As Potential Vaccines Against Infection By Shigella Flexneri App 20150290331 - Mulard; Laurence ; et al.	2015-10-15
GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3a AND X App 20150050282 - MULARD; Laurence ; et al.	2015-02-19
Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X Grant 8,815,239 - Mulard , et al. August 26, 2	2014-08-26
Glycoconjugates And Their Use As Potential Vaccines Against Infection By Shigella Flexneri App 20140161793 - PHALIPON; Armelle ; et al.	2014-06-12
Glycoconjugates And Their Use As Potential Vaccines Against Infection By Shigella Flexneri App 20130243751 - PHALIPON; Armelle ; et al.	2013-09-19
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri Grant 8,124,380 - Phalipon , et al. February 28, 2	2012-02-28
Mutants Of Glycoside Hydrolases And Uses Thereof For Synthesizing Complex Oligosaccharides And Disaccharide Intermediates App 20110144317 - Mulard; Laurence ; et al.	2011-06-16
Mutants Of Glycoside Hydrolases And Uses Thereof For Synthesizing Complex Oligosaccharides And Disaccharide Intermediates App 20110086767 - Mulard; Laurence ; et al.	2011-04-14
Immunogenic glycopeptides, screening, preparation and uses Grant 7,820,142 - Marchal , et al. October 26, 2	2010-10-26
Glycoconjugates And Use Thereof As Vaccine Against Shigella Flexneri Serotype 3a And X App 20100239584 - Mulard; Laurence ; et al.	2010-09-23
Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections App 20080293620 - Marchal; Gilles ; et al.	2008-11-27
Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri App 20080112951 - Phalipon; Armelle ; et al.	2008-05-15
Immunogenic glycopeptides, screening, preparation and uses App 20060067888 - Marchal; Gilles ; et al.	2006-03-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.